HAN Fangfang, DONG Yun, ZHU Yuan, HAN Chenyan. Effect of Huangbai Honghua Powder in preventing antitumor drug-related phlebitis[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 102-105. DOI: 10.7619/jcmp.20211669
Citation: HAN Fangfang, DONG Yun, ZHU Yuan, HAN Chenyan. Effect of Huangbai Honghua Powder in preventing antitumor drug-related phlebitis[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 102-105. DOI: 10.7619/jcmp.20211669

Effect of Huangbai Honghua Powder in preventing antitumor drug-related phlebitis

  •   Objective  To observe effect of Huangbai Honghua Powder in preventing phlebitis caused by antitumor drugs.
      Methods  A total of 270 patients using anti-tumor drugs were randomly divided into three groups. A group (n=90) used Huangbai Honghua Powder for external application, B group (n=90) used hydrocortisone butyrate cream for external application, and C group (n=90) used external application of hydrocortisone butyrate cream and Huangbai Honghua Powder. The incidence of phlebitis and the occurrence of pain in the three groups were observed.
      Results  The incidence rates of phlebitis and pain in the group C showed significant differences when compared with those in the groups A and B (P < 0.05).
      Conclusion  External application of hydrocortisone butyrate cream and Huangbai Honghua Powder can effectively prevent the occurrence of antitumor drug-related phlebitis, and is higher in safety.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return